JP2018516962A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516962A5 JP2018516962A5 JP2017564108A JP2017564108A JP2018516962A5 JP 2018516962 A5 JP2018516962 A5 JP 2018516962A5 JP 2017564108 A JP2017564108 A JP 2017564108A JP 2017564108 A JP2017564108 A JP 2017564108A JP 2018516962 A5 JP2018516962 A5 JP 2018516962A5
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- protein
- conjugate
- composition
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021129726A JP2021185152A (ja) | 2015-06-08 | 2021-08-06 | 多糖−タンパク質結合体の吸着およびそれから得られた多価のワクチン製剤を改善するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2185MU2015 | 2015-06-08 | ||
| IN2185/MUM/2015 | 2015-06-08 | ||
| PCT/IB2016/053265 WO2016199003A1 (en) | 2015-06-08 | 2016-06-03 | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021129726A Division JP2021185152A (ja) | 2015-06-08 | 2021-08-06 | 多糖−タンパク質結合体の吸着およびそれから得られた多価のワクチン製剤を改善するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018516962A JP2018516962A (ja) | 2018-06-28 |
| JP2018516962A5 true JP2018516962A5 (enExample) | 2019-07-11 |
| JP7258463B2 JP7258463B2 (ja) | 2023-04-17 |
Family
ID=57503115
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564108A Active JP7258463B2 (ja) | 2015-06-08 | 2016-06-03 | 多糖－タンパク質結合体の吸着およびそれから得られた多価のワクチン製剤を改善するための方法 |
| JP2021129726A Pending JP2021185152A (ja) | 2015-06-08 | 2021-08-06 | 多糖−タンパク質結合体の吸着およびそれから得られた多価のワクチン製剤を改善するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021129726A Pending JP2021185152A (ja) | 2015-06-08 | 2021-08-06 | 多糖−タンパク質結合体の吸着およびそれから得られた多価のワクチン製剤を改善するための方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10729780B2 (enExample) |
| EP (1) | EP3302542A4 (enExample) |
| JP (2) | JP7258463B2 (enExample) |
| KR (2) | KR102876828B1 (enExample) |
| CN (1) | CN107847571A (enExample) |
| AU (2) | AU2016276269B2 (enExample) |
| CA (1) | CA2988366C (enExample) |
| CO (1) | CO2017012628A2 (enExample) |
| EA (1) | EA201792470A1 (enExample) |
| IL (1) | IL256118B (enExample) |
| MX (1) | MX2017015985A (enExample) |
| MY (1) | MY187461A (enExample) |
| PE (1) | PE20180460A1 (enExample) |
| PH (1) | PH12017502244A1 (enExample) |
| SA (1) | SA517390495B1 (enExample) |
| WO (1) | WO2016199003A1 (enExample) |
| ZA (1) | ZA201708325B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI807252B (zh) | 2015-05-04 | 2023-07-01 | 美商輝瑞股份有限公司 | Ｂ型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途 |
| CA2988366C (en) * | 2015-06-08 | 2021-12-07 | Serum Institute Of India Private Ltd. | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof. |
| CN106822884B (zh) * | 2016-12-28 | 2021-04-30 | 北京民海生物科技有限公司 | 一种多价肺炎球菌荚膜多糖结合疫苗的制备方法 |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
| KR102701633B1 (ko) | 2017-02-24 | 2024-09-02 | 머크 샤프 앤드 돔 엘엘씨 | 폐렴구균 접합체 백신 제제 |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| CA3074706A1 (en) * | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| BR112020011414B8 (pt) | 2017-12-06 | 2023-01-31 | Merck Sharp & Dohme | Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae |
| CN108524926B (zh) * | 2018-06-29 | 2021-06-29 | 康希诺生物股份公司 | 一种多价肺炎球菌结合疫苗的制剂组合及其应用 |
| GB201818517D0 (en) * | 2018-11-13 | 2018-12-26 | Univ Liverpool John Moores | Nanoparticles and uses thereof |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| CN114025790A (zh) * | 2019-06-05 | 2022-02-08 | 默沙东公司 | 免疫原性血清型35b肺炎球菌多糖-蛋白缀合物和用于制备其的缀合方法 |
| US12473379B2 (en) | 2019-09-06 | 2025-11-18 | Serum Institute Of India Private Limited | Method for obtaining purified bacterial polysaccharides |
| CN113607939B (zh) * | 2021-08-05 | 2024-10-22 | 艾美探索者生命科学研发有限公司 | 肺炎球菌多糖结合疫苗各型结合原液吸附率测定方法 |
| CN115006522B (zh) * | 2022-06-16 | 2025-08-22 | 北京智飞绿竹生物制药有限公司 | 一种双价痢疾结合物组合疫苗的制备方法 |
| CA3232076A1 (en) * | 2023-04-17 | 2025-04-14 | Serum Institute Of India Private Limited | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| ES2461350T3 (es) * | 2003-01-30 | 2014-05-19 | Novartis Ag | Vacunas inyectables contra múltiples serogrupos de meningococos |
| CA2844154C (en) | 2003-08-06 | 2016-12-20 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| BRPI0610297A2 (pt) * | 2005-04-18 | 2010-06-08 | Novartis Vaccines & Diagnostic | expressão de antìgeno de superfìcie de vìrus da hepatite b para a preparação de vacina |
| BRPI0620460B8 (pt) * | 2005-12-22 | 2021-05-25 | Glaxosmithkline Biologicals Sa | uso de composição imunogênica para bebês, e, processo para produzir uma vacina |
| WO2007071786A2 (en) * | 2005-12-23 | 2007-06-28 | Glaxosmithkline Biologicals Sa | Conjugate vaccines |
| TW200806315A (en) * | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| BRPI0813644B8 (pt) | 2007-06-26 | 2021-05-25 | Glaxosmithkline Biologicals Sa | composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| CA2819366A1 (en) | 2010-12-10 | 2012-06-14 | Merck Sharp & Dohme Corp. | Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions |
| MX354103B (es) * | 2012-01-30 | 2018-02-13 | Serum Inst India Ltd | Composicion inmunogenica. |
| KR102057217B1 (ko) | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| DK3421051T3 (da) * | 2012-08-16 | 2020-06-22 | Pfizer | Fremgangsmåder til glycokonjugering og sammensætninger |
| CN103893751B (zh) * | 2014-03-26 | 2016-04-20 | 天津康希诺生物技术有限公司 | 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法 |
| CA2988366C (en) * | 2015-06-08 | 2021-12-07 | Serum Institute Of India Private Ltd. | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof. |
-
2016
- 2016-06-03 CA CA2988366A patent/CA2988366C/en active Active
- 2016-06-03 MY MYPI2017704714A patent/MY187461A/en unknown
- 2016-06-03 CN CN201680040596.5A patent/CN107847571A/zh active Pending
- 2016-06-03 AU AU2016276269A patent/AU2016276269B2/en active Active
- 2016-06-03 JP JP2017564108A patent/JP7258463B2/ja active Active
- 2016-06-03 WO PCT/IB2016/053265 patent/WO2016199003A1/en not_active Ceased
- 2016-06-03 EP EP16806975.5A patent/EP3302542A4/en active Pending
- 2016-06-03 PE PE2017002539A patent/PE20180460A1/es unknown
- 2016-06-03 EA EA201792470A patent/EA201792470A1/ru unknown
- 2016-06-03 MX MX2017015985A patent/MX2017015985A/es unknown
- 2016-06-03 US US15/580,653 patent/US10729780B2/en active Active
- 2016-06-03 KR KR1020237045298A patent/KR102876828B1/ko active Active
- 2016-06-03 KR KR1020187000352A patent/KR102690378B1/ko active Active
-
2017
- 2017-12-05 IL IL256118A patent/IL256118B/en unknown
- 2017-12-07 CO CONC2017/0012628A patent/CO2017012628A2/es unknown
- 2017-12-07 ZA ZA2017/08325A patent/ZA201708325B/en unknown
- 2017-12-07 PH PH12017502244A patent/PH12017502244A1/en unknown
- 2017-12-10 SA SA517390495A patent/SA517390495B1/ar unknown
-
2021
- 2021-08-06 JP JP2021129726A patent/JP2021185152A/ja active Pending
-
2024
- 2024-04-15 AU AU2024202450A patent/AU2024202450A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7258463B2 (ja) | 多糖－タンパク質結合体の吸着およびそれから得られた多価のワクチン製剤を改善するための方法 | |
| CA3066911C (en) | Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity | |
| US8753649B2 (en) | Polysaccharide-protein conjugate vaccines | |
| CN103623405B (zh) | 多糖-蛋白轭合物疫苗 | |
| CA2863178C (en) | Immunogenic composition | |
| JP2020533438A5 (enExample) | ||
| JP2020533442A5 (enExample) | ||
| JP2019513821A5 (enExample) | ||
| MX2012010388A (es) | Proceso de conjugacion de polisacaridos bacterianos con proteinas portadoras. | |
| US20230115072A1 (en) | Immunogenic Compositions of Polysaccharide-Protein Pegylated Compounds | |
| KR20190044663A (ko) | 네이세리아 메닌기티디스 백신 | |
| CA3201450A1 (en) | Bacterial protein carriers and conjugation methods | |
| CN108743936B (zh) | 一种细菌多糖结合疫苗及其制备方法与应用 | |
| Michon | Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy | |
| NZ738090B2 (en) | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof | |
| RU2023120100A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2020112314A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2020112308A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель |